POWDER BEING RICH IN MILK-ORIGIN COMPLEX LIPIDS
    1.
    发明申请
    POWDER BEING RICH IN MILK-ORIGIN COMPLEX LIPIDS 审中-公开
    粉末在奶牛复合脂肪中的丰富

    公开(公告)号:US20090269458A1

    公开(公告)日:2009-10-29

    申请号:US12088224

    申请日:2006-09-27

    IPC分类号: A23C9/18 A23C9/142 A23C1/14

    摘要: Manufacture a powder with high milk-derived complex lipid content that contains milk-derived phospholipids and milk-derived ganglioside at high concentrations, which contains protein by 15 to 35 percent by dry weight and fat by 45 to 60 percent by dry weight, wherein the content of milk-derived complex lipids is 20 percent by dry weight or more, and which can be utilized as a material for functional food, mother's milk substitute or drug, by means of adjusting the pH value of a butter serum or butter serum powder reconstituted liquid to a range of 4.0 to 5.0, adding calcium chloride to promote coagulation of protein, removing the produced sediments, filtering the supernatant by means of ultrafiltration or microfiltration, and then drying the obtained concentrate.

    摘要翻译: 以高浓度制造含有乳源性磷脂和乳源神经节苷脂的高乳衍生复合脂质含量的粉末,其含有15〜35%的干重和45〜60%的干重的蛋白质,其中, 乳源性复合脂质的含量为干重的20%以上,可以通过调整黄油血清或黄油血清粉末的pH值而重新配制,可用作功能性食品,母乳替代物或药物的材料。 液体至4.0〜5.0的范围,加入氯化钙促进蛋白质凝结,除去生成的沉淀物,通过超滤或微滤过滤上清液,然后干燥得到的浓缩物。

    Fat Accumulation Inhibitor
    3.
    发明申请
    Fat Accumulation Inhibitor 审中-公开
    脂肪蓄积抑制剂

    公开(公告)号:US20090253658A1

    公开(公告)日:2009-10-08

    申请号:US12296222

    申请日:2007-04-06

    IPC分类号: A61K31/66 C07F9/06

    摘要: To provide a fat accumulation inhibitor and a food or drink for inhibiting fat accumulation, a visceral fat accumulation inhibitor and a food or drink for inhibiting visceral fat accumulation, or an agent for accelerating increase and/or inhibiting decrease of an adiponectin concentration in blood and a food or drink for accelerating increase and/or inhibiting decrease of an adiponectin concentration in blood.A fat accumulation inhibitor for a fat cell, which comprises a milk-derived phospholipid as an active ingredient, and a food or drink for inhibiting fat accumulation in a fat cell, which comprises a milk-derived phospholipid. A visceral fat accumulation inhibitor comprising a sphingosine-containing phospholipid or a derivative thereof as an active ingredient, and a food or drink for inhibiting visceral fat accumulation. An agent for accelerating increase and/or inhibiting decrease of an adiponectin concentration in blood, which comprises a sphingosine-containing phospholipid or a derivative thereof as an active ingredient, and a food or drink for accelerating increase and/or inhibiting decrease of an adiponectin concentration in blood.

    摘要翻译: 提供一种脂肪蓄积抑制剂和用于抑制脂肪蓄积的食物或饮料,内脏脂肪蓄积抑制剂和用于抑制内脏脂肪蓄积的食品或饮料,或用于加速和/或抑制血液中脂联素浓度降低的试剂,以及 用于促进血液中脂联素浓度增加和/或抑制降低的食物或饮料。 一种脂肪蓄积抑制剂,其包含乳源性磷脂作为活性成分的脂肪蓄积抑制剂,以及包含乳源性磷脂的脂肪细胞中抑制脂肪蓄积的食品或饮料。 含有鞘氨醇的磷脂或其衍生物作为活性成分的内脏脂肪蓄积抑制剂和抑制内脏脂肪蓄积的食品或饮料。 用于促进增加和/或抑制血液中脂联素浓度降低的药物,其包含含鞘氨醇的磷脂或其衍生物作为活性成分,以及用于加速和/或抑制脂联素浓度降低的食品或饮料 在血中

    Medicine, Food And Drink Or Feed Containing Sphingomyelin
    4.
    发明申请
    Medicine, Food And Drink Or Feed Containing Sphingomyelin 审中-公开
    医药,食品和饮料或含有鞘磷脂的饲料

    公开(公告)号:US20120208783A1

    公开(公告)日:2012-08-16

    申请号:US13347464

    申请日:2012-01-10

    IPC分类号: A61K31/688 A61P25/00 C07F9/09

    摘要: It is intended to find novel pharmaceutical use of sphingomyelin and to provide preventive or therapeutic agents for various diseases as well as a food and drink product and feed comprising any of these agents. The present invention provides a pharmaceutical agent which contains sphingomyelin as an active ingredient and is any of the following agents: 1) a sialomucin secretion promoter, 2) an agent for preventing drunken sickness (hangover), 3) an antiallergic agent, 4) an antioxidant, 5) an agent for defending against infection, 6) a hair growth agent, 7) a therapeutic agent for demyelinating disease, 8) an anti-pigmentation agent, 9) an anti-inflammatory agent, and 10) an agent for improving learning ability. The present invention also provides a food and drink product or feed, characterized by comprising the agent. It is preferred that the sphingomyelin should be derived from milk.

    摘要翻译: 旨在找到鞘磷脂的新药用途,并提供各种疾病的预防或治疗剂,以及包含任何这些药剂的食品和饮料产品和饲料。 本发明提供含有鞘磷脂作为活性成分的药剂,其为以下药剂:1)唾液酸粘蛋白分泌促进剂,2)防酒醉药(宿醉)3,抗过敏剂4) 抗氧化剂,5)防止感染的药剂,6)毛发生长剂,7)脱髓鞘疾病的治疗剂,8)抗色素沉着剂,9)抗炎剂,和10)改善剂 学习能力 本发明还提供一种食品和饮料产品或饲料,其特征在于包含该试剂。 鞘磷脂优选来源于牛奶。

    Fat Accumulation Inhibitor and Method of Use Thereof
    5.
    发明申请
    Fat Accumulation Inhibitor and Method of Use Thereof 审中-公开
    脂肪蓄积抑制剂及其使用方法

    公开(公告)号:US20120077780A1

    公开(公告)日:2012-03-29

    申请号:US13240739

    申请日:2011-09-22

    摘要: The present disclosure relates to a method of inhibiting a fat accumulation for a fat cell in a subject, which includes administering a fat accumulation inhibitor for a fat cell which includes a milk-derived phospholipid as an active ingredient to the subject. The present disclosure also relates to a method of inhibiting a visceral fat accumulation in a subject, which includes administering the visceral fat accumulation inhibitor which includes a sphingosine-containing phospholipid as an active ingredient to the subject. The present disclosure also relates to a method of accelerating increase and/or inhibiting decrease of an adiponectin concentration in blood, which includes administering an agent which includes a sphingosine-containing phospholipid as an active ingredient to the blood. The present disclosure also relates to a method of inhibiting a fat accumulation for a fat cell in a subject, which includes administering a milk-derived phospholipid to a subject.

    摘要翻译: 本公开涉及抑制受试者中的脂肪细胞的脂肪蓄积的方法,其包括向受试者施用包含作为有效成分的乳源性磷脂的脂肪细胞的脂肪蓄积抑制剂。 本公开还涉及抑制受试者内脏脂肪蓄积的方法,其包括向受试者施用含有鞘氨醇的磷脂作为活性成分的内脏脂肪蓄积抑制剂。 本公开还涉及一种促进血液中脂联素浓度增加和/或抑制降低的方法,其包括向血液中施用含有鞘氨醇的磷脂作为活性成分的药剂。 本公开还涉及抑制受试者中的脂肪细胞的脂肪蓄积的方法,其包括向受试者施用乳源性磷脂。

    Medicine, Food and Drink or Feed Containing Sphingomyelin
    7.
    发明申请
    Medicine, Food and Drink or Feed Containing Sphingomyelin 审中-公开
    医药,饮食或含有鞘磷脂的饲料

    公开(公告)号:US20100048928A1

    公开(公告)日:2010-02-25

    申请号:US11992365

    申请日:2006-09-22

    IPC分类号: C07F9/09

    摘要: It is intended to find novel pharmaceutical use of sphingomyelin and to provide preventive or therapeutic agents for various diseases as well as a food and drink product and feed comprising any of these agents. The present invention provides a pharmaceutical agent which contains sphingomyelin as an active ingredient and is any of the following agents: 1) a sialomucin secretion promoter, 2) an agent for preventing drunken sickness (hangover), 3) an antiallergic agent, 4) an antioxidant, 5) an agent for defending against infection, 6) a hair growth agent, 7) a therapeutic agent for demyelinating disease, 8) an anti-pigmentation agent, 9) an anti-inflammatory agent, and 10) an agent for improving learning ability. The present invention also provides a food and drink product or feed, characterized by comprising the agent. It is preferred that the sphingomyelin should be derived from milk.

    摘要翻译: 旨在找到鞘磷脂的新药用途,并提供各种疾病的预防或治疗剂,以及包含任何这些药剂的食品和饮料产品和饲料。 本发明提供含有鞘磷脂作为活性成分的药剂,其为以下药剂:1)唾液酸粘蛋白分泌促进剂,2)防酒醉药(宿醉)3,抗过敏剂4) 抗氧化剂,5)防止感染的药剂,6)毛发生长剂,7)脱髓鞘疾病的治疗剂,8)抗色素沉着剂,9)抗炎剂,和10)改善剂 学习能力 本发明还提供一种食品和饮料产品或饲料,其特征在于包含该试剂。 鞘磷脂优选来源于牛奶。